Skip to main content

Table 2 Surveillance drug resistance mutations patterns for patients

From: Local phylogenetic analysis identifies distinct trends in transmitted HIV drug resistance: implications for public health interventions

 

TDR Mutations

 

Patient

NRTI

NNRTI

PI

1

D67N, K219Q

  

2

D67N, K219Q

  

3

K65KR, D67N, K219Q

  

4

 

K103N

 

5

D67N, K219Q

  

6

D67N, K219Q

 

M46LM

7

D67N, K219Q

  

8

D67N, K219Q

  

9

D67N, K219Q

  

10

T215C

K103N

 

11

D67N, K70R, M184V, T215F, K219E

K103N

L90M

12

D67N, K219Q

  

13

K70R

  

14

D67N, K219Q

  

15

D67N, K219Q

  

16

D67N, K219Q

  

17

D67N, K219Q

  

18

D67N, K219Q

  

19

D67N, K219Q

  
  1. Prevalence of each TDR mutation among the 155 specimens were: D67N (10.3%), K219Q (9.7%), K103N (1.9%), K70R (1.3%), with all others at 0.6%.
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us